Advertisement

European Journal of Clinical Pharmacology

, Volume 25, Issue 5, pp 679–682 | Cite as

Sex differences in the pharmacokinetics of salicylates

  • Z. Trnavská
  • K. Trnavský
Originals

Summary

The kinetics of disposition of total and free salicylic acid (SA) in blood plasma was evaluated after single and multiple oral administration of acetylsalicylic acid (ASA) to healthy female and male volunteers. In both single and multiple dose studies significant sex differences were found in the plasma levels of SA, which were due, at least in part, to individual, sex-determined differences in the rate of absorption and elimination of SA; a slower absorption rate in men reduced the magnitude of the peak plasma levels of SA. The corresponding area under concentration-time curves were always significantly lower. The elimination rate of SA in men was increased in comparison with women. The higher plasma clearance in men resulted from the kinetics of absorption and elimination. The sex differences appear to be clinical significance, since men achieved lower plasma levels of SA than women after the same weight-adjusted dose of ASA.

Key words

salicylic acid sex differences acetylsalicylic acid pharmacokinetics single and multiple doses elimination absorption 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Drucker MM, Blondheim SH, Wislicki L (1964) Factors affecting acetylation in vivo of para-aminobenzoic acid by human subjects. Clin Sci 27:133–135Google Scholar
  2. 2.
    Graham GG, Champion GD, Day RO, Paull PD (1977) Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis. Clin Pharmacol Ther 22:410–420Google Scholar
  3. 3.
    Gupta N, Sarkissian Em Paulus HE (1975) Correlation of plateau serum salicylate level with rate of salicylate metabolism. Clin Pharmacol Ther 18:351–355Google Scholar
  4. 4.
    Hollister L, Levy G (1965) Some aspects of salicylate distribution and metabolism in man. J Pharm Sci 54:1126–1129Google Scholar
  5. 5.
    Levy G (1965) Pharmacokinetics of salicylate elimination in man. J Pharm Sci 54:959–967Google Scholar
  6. 6.
    Levy G (1968) The study of salicylate pharmacokinetics in intoxicated infants and children. Clin Toxicol 1:407–424Google Scholar
  7. 7.
    Levy G (1979) Pharmacokinetics of salicylate in man. Drug Metab Rev 9:3–19Google Scholar
  8. 8.
    Levy G, Hollister L (1964) Inter- and intrasubject variations in drug absorption kinetics. J Pharm Sci 53:1446–1452Google Scholar
  9. 9.
    Levy G, Leonards JR (1966) Absorption, metabolism and excretion of salicylates. In: Smith MJH, Smith PK (eds). The Salicylates: A critical bibliographic review. Interscience, New York, pp 5–48Google Scholar
  10. 10.
    Levy G, Tsuchiya T (1972) Salicylate accumulation kinetics in man. N Engl J Med 287:430–432Google Scholar
  11. 11.
    Levy G, Tsuchiya T, Amsel LP (1971) Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetic of salicylate elimination in man. Clin Pharmacol Ther 13:258–268Google Scholar
  12. 12.
    Levy G, Vogel AW, Amsel LP (1969) Capacity-limited salicylurate formation during prolonged administration of aspirin to healthy human subjects. J Pharm Sci 50:503–504Google Scholar
  13. 13.
    Levy G, Yaffe SJ (1974) Relationship between dose and apparent volume of distribution of salicylate in children. Pediatrics 54:713–717Google Scholar
  14. 14.
    Miaskiewicz SL, Shively CA, Vesel ES (1982) Sex differences in absorption kinetics of sodium salicylate. Clin Pharmacol Ther 31:30–37Google Scholar
  15. 15.
    Müller FO, Hundt HKL, Müller DG (1977) Pharmacokinetic and pharmacodynamic implications of long-term administration of non-steroidal anti-inflammatory agents. Int J Clin Pharmacol 15:397–402Google Scholar
  16. 16.
    Notari RE (1980) Biopharmaceutics and clinical pharmacokinetics. Marcel Dekker, New York Basel, pp 46–103Google Scholar
  17. 17.
    Saltzman A (1948) Fluorimetric method for the estimation of salicylate in blood. J Biol Chem 174:399–404Google Scholar
  18. 18.
    Sechserová M, Sechser T, Rašková H, Ječná J, Elis J, Vaněček J (1975) Sexual differences in the metabolism of salicylates. Arzneimittelforsch 25:1581–1582Google Scholar
  19. 19.
    Trnavský K, Zachar M (1975) Některé aspekty úlohy aspirinesterázy v metabolismu salicylanú. Čas lék česk 114:1258–1260Google Scholar
  20. 20.
    Trnavský K, Zachar M (1977) Pohlavní rozdíly v sérových hladinách salicylové kyseliny. Čas lék čes 116:1545–1547Google Scholar
  21. 21.
    Zathurecký L, Jankú I, Chalabala M, Modr Z (1980) Biofarmácia a farmakokinetika, Osveta, n.p. Martin, pp 92–156Google Scholar

Copyright information

© Springer-Verlag 1983

Authors and Affiliations

  • Z. Trnavská
    • 1
  • K. Trnavský
    • 1
  1. 1.Research Institute for Rheumatic DiseasesPieštanyCzechoslovakia

Personalised recommendations